External use pharmaceutical preparation for curing mycotic infection

A technology for topical drugs and fungal infections, applied in the direction of antifungal agents, drug combinations, aerosol delivery, etc., can solve the problems of secondary infection, incomplete sterilization, poor drug dependence of patients, etc., to improve the cure rate, good resistance The effect of inflammation and antipruritic effect

Inactive Publication Date: 2012-10-10
NANJING ZHENGKUAN MEDICAL TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still some problems in the antifungal field, such as slow onset of action, incomplete sterilization, high recurrence rate, persistent healing, and many patients suffer
In

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External use pharmaceutical preparation for curing mycotic infection
  • External use pharmaceutical preparation for curing mycotic infection
  • External use pharmaceutical preparation for curing mycotic infection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The preparation of embodiment 1 compound ointment

[0020] Ointment Prescription:

[0021]

[0022] Preparation process: first heat and melt glycerol monostearate on a water bath, then add liquid paraffin and heat to 75°C±2°C and keep it to form an oil phase; dissolve terbinafine hydrochloride and cetylpyridinium chloride in 1, 2-Propanediol and deionized water, then add Tween 80 and preservative, stir well and heat to 75°C±2°C and keep it to form a water phase; finally add the oil phase to the water phase slowly, stirring while adding until it condenses to obtain an ointment.

Embodiment 2

[0023] The preparation of embodiment 2 compound ointment

[0024] Ointment Prescription:

[0025]

[0026] Preparation process: first heat and dissolve glycerol monostearate on a water bath, then add liquid paraffin and heat to 75°C±2°C and keep it to form an oil phase; dissolve terbinafine hydrochloride and cetylpyridinium chloride in 1, 2-Propanediol and deionized water, then add Tween 80 and preservative, stir well and heat to 75°C±2°C and keep it to form a water phase; finally add the oil phase to the water phase slowly, stirring while adding until it condenses to obtain an ointment.

Embodiment 3

[0027] The preparation of embodiment 3 compound ointment

[0028] Ointment Prescription:

[0029]

[0030] Preparation process: first heat and dissolve glycerol monostearate on a water bath, then add liquid paraffin and heat to 75°C±2°C and keep it to form an oil phase; dissolve terbinafine hydrochloride and cetylpyridinium chloride in 1, 2-Propanediol and deionized water, then add Tween 80 and preservative, stir well and heat to 75°C±2°C and keep it to form a water phase; finally, slowly add the oil phase to the water phase, stirring while adding until it condenses to obtain an ointment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an external use pharmaceutical preparationfor curing mycotic infection, which is composed of active ingredients and medical auxiliary materials, wherein the active ingredients are terbinafine hydrochloride and cetylpyridinium chloride, and preferably, the weight ratio of the terbinafine hydrochloride and the cetylpyridinium chloride is 1-5 to 1. The medicine provided by the invention has better fungus killing effect, is low in rate of relapse, and is anti-inflammatory and antipruritic.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to an external pharmaceutical preparation for antifungal infection. Background technique [0002] Superficial skin fungal infectious diseases account for a high proportion of skin diseases, are generally easy to relapse, and are difficult to cure, and belong to one of the intractable skin diseases. Clinically common skin fungal infectious diseases include tinea manuum, tinea pedis, jock itch, tinea corporis, tinea capitis, etc. The symptoms are mainly manifested in local skin moist flushing, erosion, maceration and whitish or small blisters, unbearable itching of the skin, erysipelas and lymphangitis often caused by secondary infection after scratching, easy keratosis and desquamation after drying, chapped. Can be contagious, easy to relapse. The main causes of skin fungal infections are Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4425A61K9/06A61P17/00A61P31/10A61K31/137
Inventor 不公告发明人
Owner NANJING ZHENGKUAN MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap